Harris Williams Advises GSL Solutions, Inc. on its Sale to BD
Harris Williams has successfully advised GSL Solutions, Inc. on its sale to BD (Becton, Dickinson and Company), a global leader in medical technology. The transaction, led by key figures including Andy Dixon and Taylor Will, highlights a significant achievement in the pharmacy automation sector. With over 22 years of experience, GSL aims to expand its market presence post-acquisition. Harris Williams, a subsidiary of PNC Financial Services Group, continues to showcase its expertise in M&A advisory services.
- Successful advisory role in GSL's sale enhances Harris Williams' reputation in the medical technology sector.
- The acquisition by BD could strengthen GSL's market presence and operational capabilities.
- None.
Harris Williams, a global investment bank specializing in M&A advisory services, announces it advised GSL Solutions, Inc. (GSL) on its sale to BD (Becton, Dickinson and Company), a leading global medical technology company. The transaction was led by Andy Dixon, Taylor Will, Michael Mahoney and Naazneen Essabhoy of the Harris Williams Healthcare & Life Sciences (HCLS) Group.
“It was a pleasure working with CEO Shelton Louie, COO Joe Intile and the rest of the GSL team on this transaction,” said Andy Dixon, a managing director at Harris Williams. “We are excited to have extended our successful track record in the medical products and devices sector.”
“Over the last 22 years, GSL has built a presence in the pharmacy automation space and we’re proud to have represented the company in its sale to BD,” added Taylor Will, a vice president at Harris Williams.
Harris Williams, an investment bank specializing in M&A advisory services, advocates for sellers and buyers of companies worldwide through critical milestones and provides thoughtful advice during the lives of their businesses. By collaborating as one firm across Industry Groups and geographies, the firm helps its clients achieve outcomes that support their objectives and strategically create value. Harris Williams is committed to execution excellence and to building enduring, valued relationships that are based on mutual trust. Harris Williams is a subsidiary of the PNC Financial Services Group, Inc. (NYSE: PNC).
The Harris Williams HCLS Group has experience across a broad range of sectors, including medical products and devices; healthcare providers; payors and payor services; outsourced pharmaceutical services; healthcare IT; and pharmacy. For more information on the HCLS Group and other recent transactions, visit the HCLS Group’s section of the Harris Williams website.
Harris Williams LLC is a registered broker-dealer and member of FINRA and SIPC. Harris Williams & Co. Ltd is a private limited company incorporated under English law with its registered office at 8th Floor, 20 Farringdon Street, London EC4A 4AB, UK, registered with the Registrar of Companies for England and Wales (registration number 07078852). Harris Williams & Co. Ltd is authorized and regulated by the Financial Conduct Authority. Harris Williams & Co. Corporate Finance Advisors GmbH is registered in the commercial register of the local court of Frankfurt am Main, Germany, under HRB 107540. The registered address is Bockenheimer Landstrasse 33-35, 60325 Frankfurt am Main, Germany (email address: hwgermany@harriswilliams.com). Geschäftsführer/Directors: Jeffery H. Perkins, Paul Poggi. (VAT No. DE321666994). Harris Williams is a trade name under which Harris Williams LLC, Harris Williams & Co. Ltd and Harris Williams & Co. Corporate Finance Advisors GmbH conduct business.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210304005617/en/
FAQ
What was the recent transaction involving GSL Solutions, Inc. and BD?
Who led the advisory team for GSL's sale to BD?
How long has GSL Solutions operated in the pharmacy automation space?
What role does Harris Williams play in the recent GSL transaction?
Is Harris Williams affiliated with any financial services group?
